Pradžia › 2 tipo cukrinis diabetas › Arizona

2 tipo cukrinis diabetas klinikiniai tyrimai Arizona

22 tyrimai dėl 2 tipo cukrinis diabetas ieško dalyvių vietose Arizona.

Miestai Arizona

Oficialus tyrimo tekstas (anglų kalba)

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Pima Heart, Tucson
Eclipse Clinical Research, Tucson

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07783802

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

Gilbert Center For Family Medicine, Gilbert

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Arizona Clinical Trials - Chandler, Chandler
Elite Clinical Studies, Phoenix
Clinical Research Institute of Arizona, LLC, Sun City West
ir dar 3

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07064473

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Mission Research Institute - Gilbert, Gilbert
Helios Clinical Research - Paradise Valley, Paradise Valley
Arizona Liver Health - Peoria 85381, Peoria
ir dar 1

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07754461

A Study of PATAS Using Single Ascending Doses in Healthy Volunteers and Multiple Ascending Doses in Diabetic Subjects

Arizona Clinical Trials, Chandler

Renkami dalyviai1 fazė

Amžius nuo 18 iki 65 · Visoms lytims · Atnaujinta 2026-09-29 · NCT07223333

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

Chandler Clinical Trials, Chandler
Scottsdale Clinical Trials, Scottsdale
Sun City Research, Sun City
ir dar 1

Renkami dalyviaiLaukiami sveiki savanoriai

Amžius 55 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT06112418

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Tucson Clinical Research Institute, Tucson

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Mesa
Research Site, Phoenix
Research Site, Tucson

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07784270

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Peoria
AURORA-2 Clinical Site, Phoenix
AURORA-2 Clinical Site, Tucson

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-16 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Arizona Clinical Trials, Tucson

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-14 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Helios Clinical Research - Phoenix, Phoenix

Renkami dalyviai2 fazė

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-14 · NCT06897475

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

Research Site, Mesa
Research Site, Phoenix
Research Site, Tempe

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07662213

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

Arizona Clinical Trials - Pecos, Chandler
Arizona Clinical Trials - Broadway, Tucson

Renkami dalyviai2 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07296484

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLC, Gilbert
Synexus Clinical Research US, Inc., Phoenix
Pima Heart, Tucson

Renkami dalyviai2 fazė

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-08 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Gilbert Center for Family Medicine, Gilbert

Renkami dalyviai3 fazė

Amžius nuo 18 iki 99 · Visoms lytims · Atnaujinta 2026-09-03 · NCT07684144

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

Research Site, Sun City
Research Site, Surprise

Renkami dalyviai3 fazė

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-02 · NCT07662135

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Honor Health, Scottsdale

Renkami dalyviai3 fazė

Amžius 45 ir vyresni · Visoms lytims · Atnaujinta 2026-09-01 · NCT07797335

A Study to Identify and Characterize Patients With Type 2 Diabetes Mellitus for Possible Participation in Ongoing or Future Type 2 Diabetes Mellitus Clinical Studies

Research Site, Peoria

Renkami dalyviaiStebimasis tyrimas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-25 · NCT07606066

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus

Desert Clinical Research, Mesa

Renkami dalyviai2 fazė

Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-17 · NCT07527650

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

University of Arizona, Tucson

Renkami dalyviai3 fazė

Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06739122

Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus

Arizona Kidney Disease and Hypertension Center, Phoenix
Innovative Diabetic Center, Scottsdale

Renkami dalyviai

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-04 · NCT07187479

DISCOVERY of Risk Factors for Type 2 Diabetes in Youth

Arizona State University, Phoenix
Phoenix Children's, Phoenix

Renkami dalyviaiStebimasis tyrimas

Amžius nuo 8 iki 15 · Visoms lytims · Atnaujinta 2026-05-07 · NCT06525259

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.